Tarsus Pharmaceuticals Inc. (TARS): Price and Financial Metrics
TARS Price/Volume Stats
| Current price | $46.17 | 52-week high | $57.28 |
| Prev. close | $47.49 | 52-week low | $20.08 |
| Day low | $45.39 | Volume | 869,721 |
| Day high | $47.06 | Avg. volume | 655,327 |
| 50-day MA | $49.06 | Dividend yield | N/A |
| 200-day MA | $39.23 | Market Cap | 1.77B |
TARS Stock Price Chart Interactive Chart >
Tarsus Pharmaceuticals Inc. (TARS) Company Bio
Tarsus is a clinical-stage biopharmaceutical company headquartered in Irvine, California. Tarsus was founded in 2017 to bring innovative therapies to a range of diseases in need of better solutions, starting with Demodex blepharitis and eye care.
TARS Price Returns
| 1-mo | -8.06% |
| 3-mo | -12.39% |
| 6-mo | 33.44% |
| 1-year | 50.83% |
| 3-year | 160.11% |
| 5-year | N/A |
| YTD | -16.62% |
| 2024 | 173.43% |
| 2023 | 38.13% |
| 2022 | -34.84% |
| 2021 | -45.56% |
| 2020 | N/A |
Loading social stream, please wait...